Cedars-Sinai

Healthcare Innovation Eases Burden on ICU Staff

A Cross-Institutional Team of Physicians Create “COVID Line Team,” Serving as Hub for Placing Central and Arterial Lines in Critically Ill COVID-19 Patients, Allowing ICU Staff to Concentrate on Patient Care

Newswise — LOS ANGELES (Jan. 13, 2021) -- Throughout the COVID-19 crisis, Cedars-Sinai employees have stepped-up and stepped-in to support patients and colleagues alike. And while there has been no shortage of selflessness, one group of volunteers shines a bright light on both the innovation and teamwork spurring from the past 10 months of treating the sickest of patients.

"We saw a need and quickly identified a solution," said Evan Zahn, MD, a congenital heart disease expert, when recalling how the innovative idea came to be.

The medical innovation was first conceived by Eduardo Marbán, MD, PhD, executive director of the Smidt Heart Institute and the Mark S. Siegel Family Foundation Distinguished Professor, last March after Zahn went to him volunteering his services in response to the COVID-19 crisis.

Marbán realized that Zahn might be able to fill a huge need in expediting care of the sickest COVID-19 patients: Zahn’s special skills include inserting "lines"-thin plastic tubes placed meticulously into arteries or veins-to monitor blood pressure, oxygen levels and fluid status.

Such lines, whether placed centrally into a large vein in the neck or leg, or into an artery in the arm, were taking ICU doctors and nurses roughly 60 to 90 minutes to place in patients with COVID-19: The processes are difficult to begin with, and made more so by having to be performed using personal protective equipment and other precautions against the aerosolized virus.

The innovative concept was to create and deploy a squad of physicians highly skilled in placing central lines and arterial lines, to enable the primary ICU team to take care of critically ill COVID-19 patients without distraction. Cardiac interventionalists, like Zahn, routinely place central lines in patients multiple times a day and therefore, can do it in less time. Zahn himself had the added benefit of doing so in the tiniest of infants, as part of his work as a pediatric cardiologist, making it that much easier for him to place lines in adult patients.

"Our ICU care teams didn’t have upward of 60 minutes to spend donning and doffing PPE to perform these bedside procedures," said Zahn, director of the Guerin Family Congenital Heart Program in the Smidt Heart Institute. "Their time needed to be spent on caring for, and treating, the sickest of patients."

So, under Zahn’s leadership, a strictly voluntary "COVID line team" was quickly formed last March–comprising roughly 20 doctors with special expertise in placing these lines.

Within hours of the initial ask, Zahn said dozens of highly skilled and experienced physicians called to volunteer.

"These were busy doctors with already full-time jobs, yet they understood the severity of the crisis and knew their skill set and familiarity with these procedures could be of great service," said Zahn. "These individuals were more than willing to put themselves in harm’s way. It’s a true testament to the goodness of our Cedars-Sinai family."

Over the summer months, the number of admitted COVID-19 patients dipped at Cedars-Sinai, which meant fewer members of the central line team were needed. But over the last three weeks, as cases began to climb rapidly, the need for the volunteer group became urgent once again.

"The line team’s work allows our ICU clinicians to focus their efforts where they are most needed, while giving our patients the benefit of receiving vascular access from a highly skilled group of physicians," said Michael Nurok, MD, PhD, medical director of the Cardiac Surgery Intensive Care Unit in the Smidt Heart Institute. "This is another great example of the collaborative spirit and ingenuity that makes Cedars-Sinai such a unique place to receive care."

Robert Wong, MD, director of Medical Student Education in the Department of Anesthesiology at Cedars-Sinai, has been the point person for the complex logistics involved in making the line team function.

"The number of COVID-19 patients has increased since last spring," said Wong. "We are working to get as much help as we can, knowing everyone at the medical center is trying to balance their tremendous amounts of work, while also sacrificing what they can to support our increasing patient care needs."

Zahn and Wong see no end in sight for the voluntary central line team, as cases are projected to continue rising in the wake of Christmas and New Year’s celebrations.

 "We are now performing these procedures in numbers we haven’t seen before," said Zahn. "The number of patients is unprecedented, and we are doing our best to support our incredible ICU care team heroes. These selfless individuals, our ICU nurses, respiratory technicians and doctors, are the real story."

Read more from the Cedars-Sinai Blog: Mission Critical: Racial Disparities in COVID-19




Filters close

Showing results

110 of 4573
Released: 15-Jan-2021 5:40 PM EST
Research Links Social Isolation to COVID-19 Protocol Resistance
Humboldt State University

As health officials continue to implore the public to wear masks and practice social distancing, recent research by Humboldt State University Psychology Professor Amber Gaffney provides key insights into connections between social isolation, conspiratorial thinking, and resistance to COVID-19 protocols.

Newswise: Rapid blood test identifies COVID-19 patients at high risk of severe disease
Released: 15-Jan-2021 5:35 PM EST
Rapid blood test identifies COVID-19 patients at high risk of severe disease
Washington University in St. Louis

Scientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.

Released: 15-Jan-2021 2:55 PM EST
COVID-19 deaths really are different. But best practices for ICU care should still apply, studies suggest.
Michigan Medicine - University of Michigan

COVID-19 deaths are indeed different from other lung failure deaths, according to two recent studies, with 56% of COVID-19 patients dying primarily from the lung damage caused by the virus, compared with 22% of those whose lungs fail due to other causes. But, the researchers conclude, the kind of care needed to help sustain people through the worst cases of all forms of lung failure is highly similar, and just needs to be fine-tuned.

Released: 15-Jan-2021 2:50 PM EST
45% of adults over 65 lack online medical accounts that could help them sign up for COVID-19 vaccinations
Michigan Medicine - University of Michigan

As the vaccination of older adults against COVID-19 begins across the country, new poll data suggests that many of them don’t yet have access to the “patient portal” online systems that could make it much easier for them to schedule a vaccination appointment. In all, 45% of adults aged 65 to 80 had not set up an account with their health provider’s portal system.

Released: 15-Jan-2021 1:30 PM EST
New England Journal of Medicine publishes COVID-19 treatment trial results
University of Texas at San Antonio

A clinical trial involving COVID-19 patients hospitalized at UT Health San Antonio and University Health, among roughly 100 sites globally, found that a combination of the drugs baricitinib and remdesivir reduced time to recovery, according to results published Dec. 11 in the New England Journal of Medicine.

Released: 15-Jan-2021 12:40 PM EST
DNA test can quickly identify pneumonia in patients with severe COVID-19, aiding faster treatment
University of Cambridge

Researchers have developed a DNA test to quickly identify secondary infections in COVID-19 patients, who have double the risk of developing pneumonia while on ventilation than non-COVID-19 patients.

Released: 15-Jan-2021 12:30 PM EST
Fight CRC To Present Research Findings on The Impact of COVID-19 on the Colorectal Cancer Community at 2021 GI ASCO
Fight Colorectal Cancer

Fight Colorectal Cancer presents abstract at Gastrointestinal Cancer Symposium highlighting the need to address the barriers and opportunities for care within the colorectal cancer community during the COVID-19 pandemic

Released: 15-Jan-2021 12:25 PM EST
Technion to Award Honorary Doctorate to Pfizer CEO Dr. Albert Bourla
American Technion Society

Israel's Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.

Released: 15-Jan-2021 11:30 AM EST
UW researchers develop tool to equitably distribute limited vaccines
University of Wisconsin-Madison

Researchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.


Showing results

110 of 4573

close
1.14476